91 related articles for article (PubMed ID: 18398738)
1. Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics.
Khan NI; Cisterne A; Devidas M; Shuster J; Hunger SP; Shaw PJ; Bradstock KF; Bendall LJ
Leuk Lymphoma; 2008 Apr; 49(4):710-8. PubMed ID: 18398738
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.
Kasai S; Furuichi Y; Ando N; Kagami K; Abe M; Nakane T; Goi K; Inukai T; Saitoh S; Ohno S; Okazaki S; Nagano O; Saya H; Sugita K
Cell Death Dis; 2017 Jun; 8(6):e2857. PubMed ID: 28569787
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.
Amirghofran Z; Asiaee E; Kamazani FM
Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983
[TBL] [Abstract][Full Text] [Related]
4. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; Slater RM; von dem Borne AE; van der Schoot CE
Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
[TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
[TBL] [Abstract][Full Text] [Related]
6. miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
Avigad S; Verly IR; Lebel A; Kordi O; Shichrur K; Ohali A; Hameiri-Grossman M; Kaspers GJ; Cloos J; Fronkova E; Trka J; Luria D; Kodman Y; Mirsky H; Gaash D; Jeison M; Avrahami G; Elitzur S; Gilad G; Stark B; Yaniv I
Genes Chromosomes Cancer; 2016 Apr; 55(4):328-39. PubMed ID: 26684414
[TBL] [Abstract][Full Text] [Related]
7. CD44 and CD27 expression pattern in B cell precursor acute lymphoblastic leukemia and its clinical significance.
Kamazani FM; Bahoush GR; Aghaeipour M; Vaeli S; Amirghofran Z
Med Oncol; 2013 Mar; 30(1):359. PubMed ID: 23263849
[TBL] [Abstract][Full Text] [Related]
8. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study.
Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM
Tumori; 2010; 96(6):971-7. PubMed ID: 21388061
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
10. Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
Thörn I; Forestier E; Botling J; Thuresson B; Wasslavik C; Björklund E; Li A; Lindström-Eriksson E; Malec M; Grönlund E; Torikka K; Heldrup J; Abrahamsson J; Behrendtz M; Söderhäll S; Jacobsson S; Olofsson T; Porwit A; Lönnerholm G; Rosenquist R; Sundström C
Br J Haematol; 2011 Mar; 152(6):743-53. PubMed ID: 21250970
[TBL] [Abstract][Full Text] [Related]
11. C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance?
Allen A; Gill K; Hoehn D; Sulis M; Bhagat G; Alobeid B
Leuk Res; 2014 Sep; 38(9):1061-6. PubMed ID: 25060305
[TBL] [Abstract][Full Text] [Related]
12. A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.
Sutton R; Venn NC; Law T; Boer JM; Trahair TN; Ng A; Den Boer ML; Dissanayake A; Giles JE; Dalzell P; Mayoh C; Barbaric D; Revesz T; Alvaro F; Pieters R; Haber M; Norris MD; Schrappe M; Dalla Pozza L; Marshall GM
Br J Haematol; 2018 Feb; 180(4):550-562. PubMed ID: 29194562
[TBL] [Abstract][Full Text] [Related]
13. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
Kuiper RP; Waanders E; van der Velden VH; van Reijmersdal SV; Venkatachalam R; Scheijen B; Sonneveld E; van Dongen JJ; Veerman AJ; van Leeuwen FN; van Kessel AG; Hoogerbrugge PM
Leukemia; 2010 Jul; 24(7):1258-64. PubMed ID: 20445578
[TBL] [Abstract][Full Text] [Related]
14. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
[TBL] [Abstract][Full Text] [Related]
15. The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia.
de Bock CE; Ardjmand A; Molloy TJ; Bone SM; Johnstone D; Campbell DM; Shipman KL; Yeadon TM; Holst J; Spanevello MD; Nelmes G; Catchpoole DR; Lincz LF; Boyd AW; Burns GF; Thorne RF
Leukemia; 2012 May; 26(5):918-26. PubMed ID: 22116550
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow Th2 cytokine expression as predictor for relapse in childhood acute lymphoblastic leukemia (ALL).
Stachel D; Albert M; Meilbeck R; Kreutzer B; Haas RJ; Schmid I
Eur J Med Res; 2006 Mar; 11(3):102-13. PubMed ID: 16751110
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia.
Sandoval J; Heyn H; Méndez-González J; Gomez A; Moran S; Baiget M; Melo M; Badell I; Nomdedéu JF; Esteller M
Br J Haematol; 2013 Feb; 160(3):406-9. PubMed ID: 23110451
[No Abstract] [Full Text] [Related]
18. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
19. High frequency and poor prognosis of late childhood BCR-ABL-positive and MLL-AF4-positive ALL define the need for advanced molecular diagnostics and improved therapeutic strategies in pediatric B-ALL in Pakistan.
Iqbal Z; Akhtar T; Awan T; Aleem A; Sabir N; Rasool M; Absar M; Akram AM; Shammas MA; Shah IH; Khalid M; Taj AS; Jameel A; Alanazi A; Gill AT; Hashmi JA; Hussain A; Sabar MF; Khalid AM; Qazi MH; Karim S; Siddiqi MH; Mahmood A; Iqbal M; Saeed A; Irfan MI
Mol Diagn Ther; 2015 Oct; 19(5):277-87. PubMed ID: 26266519
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
